Gaspari Nutrition

AminoLast Watermelon Blast

F
N+ Score46
Joint & BoneServing: 14 Gram(s)Type: Other Combinations

Gaspari Nutrition AminoLast Watermelon Blast is an 'Other Combinations' supplement, providing 10 grams of an AminoLast Matrix along with various minerals. This product received an N+ Score of 46, resulting in an 'F' grade, indicating a below-average quality assessment. Key minerals such as Calcium (92 mg) and Magnesium (20 mg) are present but noted as underdosed compared to typical daily recommended values. The use of a proprietary blend for the AminoLast Matrix limits transparency regarding the specific amino acid components and their individual dosages. No ingredients are noted as being at clinical doses. This product may appeal to individuals seeking amino acid support, but the proprietary blend is a notable limitation.

About This Product

AminoLast Watermelon Blast by Gaspari Nutrition is a joint & bone supplement containing 6 active ingredients. It has earned an N+ Score of 46/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy0/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • −Several ingredients below clinically effective doses
  • −Missing several expected ingredients for its category

Ingredient Analysis (6 ingredients)

IngredientAmountDose Adequacy
Calories10.000 {Calories}N/A
Calcium92.000 mgUnder
Magnesium20.000 mgUnder
Sodium25.000 mgN/A
Protein2.000 gN/A
AminoLast Matrix10.000 gN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.